Skip to main content

Anti-NMDA Receptor Encephalitis clinical trials at UCSF

1 research study open to eligible people

Anti-NMDA receptor encephalitis is a disease where the body's immune system attacks the brain. UCSF is studying a drug called Satralizumab to see if it helps people with this condition. The trial looks at how safe and effective the drug is for patients.

Showing trials for

Last updated: